iRhythm Holdings (IRTC) Net Cash Flow (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.35% |
| Dec 31, 2025 | 63.31% |
| Sep 30, 2025 | 19.14% |
| Jun 30, 2025 | -49.35% |
| Mar 31, 2025 | 55.67% |
| Dec 31, 2024 | -222.16% |
| Sep 30, 2024 | -202.93% |
| Jun 30, 2024 | -93.88% |
| Mar 31, 2024 | 4,536.33% |
| Dec 31, 2023 | 21.67% |
| Sep 30, 2023 | -260.76% |
| Jun 30, 2023 | 133.88% |
| Mar 31, 2023 | -442.02% |
| Dec 31, 2022 | 125.34% |
| Sep 30, 2022 | -564.37% |
| Jun 30, 2022 | 119.73% |
| Mar 31, 2022 | 17.67% |
| Dec 31, 2021 | -239.69% |
| Sep 30, 2021 | 1,803.74% |
| Jun 30, 2021 | -96.93% |
| Mar 31, 2021 | 826.70% |
| Dec 31, 2020 | -149.30% |
| Sep 30, 2020 | -46.04% |
| Jun 30, 2020 | -30.06% |
| Mar 31, 2020 | 354.39% |
| Dec 31, 2019 | -175.99% |
| Sep 30, 2019 | 253.92% |
| Jun 30, 2019 | -250.00% |
| Mar 31, 2019 | 201.64% |
| Dec 31, 2018 | 241.24% |
| Sep 30, 2018 | -168.50% |
| Jun 30, 2018 | -64.52% |
| Mar 31, 2018 | 166.35% |
| Dec 31, 2017 | -387.55% |
| Sep 30, 2017 | 513.96% |
| Jun 30, 2017 | 101.85% |
| Mar 31, 2017 | -178.59% |
| Dec 31, 2016 | 1,528.01% |
| Sep 30, 2016 | 39.04% |
| Jun 30, 2016 | 51.92% |
| Mar 31, 2016 | -160.63% |